Angel'Ina
✅ Low Risk
FEI: 3003661834 • Paris, Paris • FRANCE
FEI Number
3003661834
Location
Paris, Paris
Country
FRANCEAddress
226 rue Saint Denis, , Paris, Paris, France
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/22/2003 | 34BFT99CHOCOLATE AND COCOA, N.E.C. | 482NUTRIT LBL | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Angel'Ina's FDA import refusal history?
Angel'Ina (FEI: 3003661834) has 1 FDA import refusal record(s) in our database, spanning from 4/22/2003 to 4/22/2003.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Angel'Ina's FEI number is 3003661834.
What types of violations has Angel'Ina received?
Angel'Ina has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Angel'Ina come from?
All FDA import refusal data for Angel'Ina is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.